These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1689 related items for PubMed ID: 28948412

  • 1. Rapid Fecal Calprotectin Test and Symptom Index in Monitoring the Disease Activity in Colonic Inflammatory Bowel Disease.
    Puolanne AM, Kolho KL, Alfthan H, Ristimäki A, Mustonen H, Färkkilä M.
    Dig Dis Sci; 2017 Nov; 62(11):3123-3130. PubMed ID: 28948412
    [Abstract] [Full Text] [Related]

  • 2. Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel disease.
    D'Haens G, Ferrante M, Vermeire S, Baert F, Noman M, Moortgat L, Geens P, Iwens D, Aerden I, Van Assche G, Van Olmen G, Rutgeerts P.
    Inflamm Bowel Dis; 2012 Dec; 18(12):2218-24. PubMed ID: 22344983
    [Abstract] [Full Text] [Related]

  • 3. Fecal HMGB1 Reveals Microscopic Inflammation in Adult and Pediatric Patients with Inflammatory Bowel Disease in Clinical and Endoscopic Remission.
    Palone F, Vitali R, Cucchiara S, Mennini M, Armuzzi A, Pugliese D, DʼIncà R, Barberio B, Stronati L.
    Inflamm Bowel Dis; 2016 Dec; 22(12):2886-2893. PubMed ID: 27755215
    [Abstract] [Full Text] [Related]

  • 4. Fecal calprotectin correlated with endoscopic remission for Asian inflammatory bowel disease patients.
    Lin WC, Wong JM, Tung CC, Lin CP, Chou JW, Wang HY, Shieh MJ, Chang CH, Liu HH, Wei SC, Taiwan Society of Inflammatory Bowel Disease Multicenter Study.
    World J Gastroenterol; 2015 Dec 28; 21(48):13566-73. PubMed ID: 26730169
    [Abstract] [Full Text] [Related]

  • 5. Accuracy of fecal calprotectin for the prediction of endoscopic activity in patients with inflammatory bowel disease.
    Jusué V, Chaparro M, Gisbert JP.
    Dig Liver Dis; 2018 Apr 28; 50(4):353-359. PubMed ID: 29396129
    [Abstract] [Full Text] [Related]

  • 6. Comparison of three commercial fecal calprotectin ELISA test kits used in patients with Inflammatory Bowel Disease.
    Mirsepasi-Lauridsen HC, Bachmann Holmetoft U, Ingdam Halkjær S, Angeliki Krogfelt K, Munk Petersen A.
    Scand J Gastroenterol; 2016 Apr 28; 51(2):211-7. PubMed ID: 26359672
    [Abstract] [Full Text] [Related]

  • 7. Neopterin is a novel reliable fecal marker as accurate as calprotectin for predicting endoscopic disease activity in patients with inflammatory bowel diseases.
    Nancey S, Boschetti G, Moussata D, Cotte E, Peyras J, Cuerq C, Haybrard J, Charlois AL, Mialon A, Chauvenet M, Stroeymeyt K, Kaiserlian D, Drai J, Flourié B.
    Inflamm Bowel Dis; 2013 Apr 28; 19(5):1043-52. PubMed ID: 23511035
    [Abstract] [Full Text] [Related]

  • 8. Rapid faecal tests for detecting disease activity in colonic inflammatory bowel disease.
    Puolanne AM, Kolho KL, Alfthan H, Ristimäki A, Mustonen H, Färkkilä M.
    Eur J Clin Invest; 2016 Oct 28; 46(10):825-32. PubMed ID: 27438629
    [Abstract] [Full Text] [Related]

  • 9. Fecal calprotectin in assessing inflammatory bowel disease endoscopic activity: a diagnostic accuracy meta-analysis.
    Rokkas T, Portincasa P, Koutroubakis IE.
    J Gastrointestin Liver Dis; 2018 Sep 28; 27(3):299-306. PubMed ID: 30240474
    [Abstract] [Full Text] [Related]

  • 10. Fecal hemoglobin and calprotectin are equally effective in identifying patients with inflammatory bowel disease with active endoscopic inflammation.
    Mooiweer E, Fidder HH, Siersema PD, Laheij RJ, Oldenburg B.
    Inflamm Bowel Dis; 2014 Feb 28; 20(2):307-14. PubMed ID: 24374878
    [Abstract] [Full Text] [Related]

  • 11. Low Fecal Calprotectin Correlates with Histological Remission and Mucosal Healing in Ulcerative Colitis and Colonic Crohn's Disease.
    Zittan E, Kelly OB, Kirsch R, Milgrom R, Burns J, Nguyen GC, Croitoru K, Van Assche G, Silverberg MS, Steinhart AH.
    Inflamm Bowel Dis; 2016 Mar 28; 22(3):623-30. PubMed ID: 26829408
    [Abstract] [Full Text] [Related]

  • 12. Rapid fecal calprotectin level assessment and the SIBDQ score can accurately detect active mucosal inflammation in IBD patients in clinical remission: a prospective study.
    Voiosu T, Benguş A, Dinu R, Voiosu AM, Bălănescu P, Băicuş C, Diculescu M, Voiosu R, Mateescu B.
    J Gastrointestin Liver Dis; 2014 Sep 28; 23(3):273-8. PubMed ID: 25267955
    [Abstract] [Full Text] [Related]

  • 13. Fecal calprotectin measurement is a marker of short-term clinical outcome and presence of mucosal healing in patients with inflammatory bowel disease.
    Kostas A, Siakavellas SI, Kosmidis C, Takou A, Nikou J, Maropoulos G, Vlachogiannakos J, Papatheodoridis GV, Papaconstantinou I, Bamias G.
    World J Gastroenterol; 2017 Nov 07; 23(41):7387-7396. PubMed ID: 29151692
    [Abstract] [Full Text] [Related]

  • 14. Low fecal calprotectin predicts sustained clinical remission in inflammatory bowel disease patients: a plea for deep remission.
    Mooiweer E, Severs M, Schipper ME, Fidder HH, Siersema PD, Laheij RJ, Oldenburg B.
    J Crohns Colitis; 2015 Jan 07; 9(1):50-5. PubMed ID: 25518048
    [Abstract] [Full Text] [Related]

  • 15. Efficacy of noninvasive evaluations in monitoring inflammatory bowel disease activity: A prospective study in China.
    Chen JM, Liu T, Gao S, Tong XD, Deng FH, Nie B.
    World J Gastroenterol; 2017 Dec 14; 23(46):8235-8247. PubMed ID: 29290660
    [Abstract] [Full Text] [Related]

  • 16. Disease activity assessment in IBD: clinical indices and biomarkers fail to predict endoscopic remission.
    Falvey JD, Hoskin T, Meijer B, Ashcroft A, Walmsley R, Day AS, Gearry RB.
    Inflamm Bowel Dis; 2015 Apr 14; 21(4):824-31. PubMed ID: 25738372
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Fecal Human Neutrophil Peptide Levels Correlate with Intestinal Inflammation in Ulcerative Colitis.
    Kanmura S, Hamamoto H, Morinaga Y, Oda K, Fujita T, Arima S, Nasu Y, Sasaki F, Hashimoto S, Taguchi H, Setoyama H, Ido A.
    Digestion; 2016 Apr 14; 93(4):300-8. PubMed ID: 27220673
    [Abstract] [Full Text] [Related]

  • 19. Does fecal calprotectin predict relapse in patients with Crohn's disease and ulcerative colitis?
    García-Sánchez V, Iglesias-Flores E, González R, Gisbert JP, Gallardo-Valverde JM, González-Galilea A, Naranjo-Rodríguez A, de Dios-Vega JF, Muntané J, Gómez-Camacho F.
    J Crohns Colitis; 2010 Jun 14; 4(2):144-52. PubMed ID: 21122498
    [Abstract] [Full Text] [Related]

  • 20. Fecal Calprotectin as an Activity Marker of Inflammatory Bowel Disease in Children.
    Krzesiek E.
    Adv Clin Exp Med; 2015 Jun 14; 24(5):815-22. PubMed ID: 26768632
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 85.